![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
The Effect of Ribavirin Dosage on the Kinetics of Viral Load Decline and Drug Exposures in Plasma and Liver With OBV/PTV/r + DSV Treatment in Patients With Chronic Hepatitis C Virus Genotype 1a Infection
|
|
|
Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
Andrew H Talal1, Emily O Dumas2, Barbara Bauer1, Richard M Rejman1, Andrew Ocque1, Gene D Morse1, Danijela Lucic3, Gavin A Cloherty3, Jennifer King4, Hongtao Zhang2, Daniel E Cohen2, Nancy Shulman2, Jean-Michel Pawlotsky5, Christophe Hezode5
1University at Buff alo, Buff alo, New York, United States; 2AbbVie Inc., North Chicago, Illinois, United States; 3Abbott Diagnosti cs, Abbott Park, Illinois, United States; 4Roivant Sciences Inc., Durham, North Carolina, United States;
5Hopital Henri Mondor, Universite Paris-Est, Creteil, France
![0508171](../images/050817/050817-2/0508171.gif)
![0508172](../images/050817/050817-2/0508172.gif)
![0508173](../images/050817/050817-2/0508173.gif)
![0508174](../images/050817/050817-2/0508174.gif)
![0508175](../images/050817/050817-2/0508175.gif)
![0508176](../images/050817/050817-2/0508176.gif)
![0508177](../images/050817/050817-2/0508177.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|